TRIM59 and pachyonychia congenita: Furthermore, the results of the IHC assay indicated that TRIM59 levels were remarkably elevated in the gemcitabine-resistant group than in the gemcitabine-sensitive group in PC patients who received postoperative gemcitabine treatment (Fig. 2G, H).